Kenvue's interim CEO Kirk Perry met Robert F. Kennedy Jr. to try and dissuade him from listing Tylenol as a potential cause ...

Despite Kenvue’s recent underperformance relative to the Dow, analysts remain moderately optimistic about the stock’s ...

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller ...

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and ...

Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

Beyond oral care, Kenvue is aligning its strategy with the government’s Healthy China 2030 initiative, a national plan to ...

Kenvue (KVUE) stock is in focus as the company prepares a strong defense as an HHS report may link its Tylenol (acetaminophen ...

If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of ...

Research based on over 22 lakh patient records highlights high antibiotic use, poor categorisation of cough, and the need for ...

The oral health initiative is targeted at 750,000 elementary school students and their families in rural communities and ...

A recent study reveals significant gaps in cough management in India, highlighting excessive antibiotic use and a lack of ...